Tubal ligation is a surgical procedure used to permanently prevent pregnancy. It is also known as female sterilization or “getting your tubes tied.” During the procedure, the fallopian tubes are cut, burned, or blocked off to prevent eggs from traveling from the ovaries to the uterus, and sperm from reaching the eggs. Tubal ligation is considered a permanent form of birth control. It is usually done in a hospital or an outpatient clinic. It is usually done under general or regional anesthesia, meaning the patient is either put to sleep or numbed in the entire lower half of the body. The procedure typically takes 30 minutes or less. The effectiveness of tubal ligation is very high. In the first year after the procedure, less than 1 in 100 women will become pregnant. The chance of becoming pregnant increases over time, however, so it is not 100% effective. Tubal ligation can be reversed, although it is not always successful. If a woman decides she wants to become pregnant after having a tubal ligation, she may be able to have it reversed, but there is no guarantee that she will become pregnant. Reversal surgery is more successful in women who had a tubal ligation less than 10 years prior. There are some risks associated with a tubal ligation. These include infection, bleeding, and damage to nearby organs. In rare cases, a woman may experience an ectopic pregnancy after a tubal ligation.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia